Radiofrequency ablation for hepatocellular carcinoma and liver metastases: experience in Hospital La Paz.

Autor: Gómez Senent S; Department of Gastroenterology, La Paz University Hospital, Madrid, Spain. silviagsenent@yahoo.es, Gómez Raposo C, Manceñido Marcos N, Martín Chavarri S, Carrión Alonso G, Olveira Martín A, Segura Cabral JM, González Barón M
Jazyk: angličtina
Zdroj: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2006 Sep; Vol. 8 (9), pp. 688-91.
DOI: 10.1007/s12094-006-0040-x
Abstrakt: Introduction: Radiofrequency ablation for patients presenting with non-resectable primary or metastatic liver tumours seems to be a valid therapeutic alternative. In the present study, we show a descriptive list of indications, results and complications of Radiofrequency Ablation Technique for treating non-resectable solid hepatic tumours.
Materials and Methods: Twenty two patients were included in this study; eleven of them (50%) sustained liver metastases from colorectal adenocarcinoma, ten patients (45.5%) had hepatocellular carcinoma and 1 patient had insulinoma.
Results: Local recurrence rate of hepatocellular carcinoma was 22.7% and 27.3% for colorectal carcinoma, after a respective median follow-up of 21 and 14 months. Complications rate was 6.9% and technique-associated mortality rate was 0%.
Conclusions: Radiofrequency ablation is an easy to make, safe and useful technique for the treatment of primary and metastatic liver tumours.
Databáze: MEDLINE
Externí odkaz: